Skip to main content

Table 1 Correlation between kallistatin expression and clinicopathologic parameters

From: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Parameters   n Kallistatin expression P value
Low (n = 144) High (n = 168)
Age(years) < 55 149 58 91 0.0170*
≥55 163 86 77
FIGO stage I + II 60 21 39 0.0614
III + IV 250 122 128
CA125 (U/ml) < 600 122 57 65 0.6745
≥600 174 77 97
Ascites (ml) < 1000 165 67 98 0.0432*
≥1000 146 76 70
Platinum Resistant 91 30 15 0.0127*
Sensitive 45 40 51
Omentum metastasis Positive 103 101 108 0.2081
Negative 209 42 61
Lymph node metastasis Positive 72 29 27 0.2546
Negative 56 30 42
Recurrence No 81 29 52 0.0156*
Yes 181 94 87